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a-Lactalbumin is a tryptophan-rich protein fraction. A diet enriched with a-lactalbumin increases the ratio of tryptophan to the other large neutral amino
acids, which may in turn increase brain serotonin content. In stress-vulnerable individuals, a-lactalbumin improved mood and attenuated the cortisol
response after experimental stress. The aim of the present study was to investigate the effects of an a-lactalbumin-enriched diet on mood and stress response
in recovered depressed subjects and healthy controls. Forty-three subjects (twenty-three recovered depressed and twenty healthy subjects) received a-lac-
talbumin and casein (placebo) on separate days, in a double-blind randomised crossover design. On both occasions, subjects underwent a stress test (an
unsolvable mental arithmetic task with loud noise). The stress test affected mood in both conditions. Although the a-lactalbumin diet led to the expected
rises in tryptophan and tryptophan:large neutral amino acids ratio, only minimal effects were found on mood and cortisol response to experimental stress.
The results were the same for recovered depressed patients and controls. A 1 d diet enriched with a-lactalbumin is not sufficient to prevent a stress-induced
mood deterioration or a cortisol response in unmedicated, recovered depressed subjects. Future studies may investigate the effects of longer-term diets or
may investigate different samples (e.g. medicated patients).
a-Lactalbumin: Depression: Serotonin: Cortisol
There is abundant evidence that serotonin (5-hydroxytryptamine;
5-HT) plays an important role in stress-related disorders such as
major depression (Meltzer & Lowy, 1987; Maes & Meltzer,
1995). For instance, medications that augment 5-HT activity,
such as selective serotonin reuptake inhibitors and monoamine
oxidase inhibitors, are effective antidepressants (Blier & De
Montigny, 1998; Nutt et al. 1999). Furthermore, experimental
depletion of the 5-HT precursor L-tryptophan (Trp) induces symp-
toms in depression-vulnerable subjects (patients in remission or
family members of patients) but not in healthy subjects (Bell
et al. 2001; Van der Does, 2001). Conversely, Trp administration
increases 5-HT synthesis in the brain in both human subjects and
rats, and these effects are large enough to influence mood and
behaviour (Young, 1996). For example, Trp decreased aggression
and quarrelsome behaviour, and increased dominant behaviour, in
healthy volunteers (Moskowitz et al. 2001; Marsh et al. 2002;
Young & Leyton, 2002). In healthy females, Trp improved
emotion recognition (Attenburrow et al. 2003). Trp also has
some therapeutic effect in mild to moderate depression, but it is
not effective in more severe depression (Young, 1986, 1996).
It is clear, however, that boosting or depleting the 5-HT system
has opposite effects on mood, although some of these effects
are only observable in depression-vulnerable subjects.
Several studies have attempted to increase 5-HT concentrations
through dietary interventions. Although selective serotonin
reuptake inhibitors have fewer side-effects than other antidepress-
ants, and are not toxic in overdose, a sizable number of patients
do not tolerate them or fail to benefit from them (Fava, 2000).
Survey data show that many patients prematurely stop their medi-
cations because of side-effects (Consumer Reports, 2004). So, if
effective and feasible, dietary interventions may comprise a
viable addition or alternative to antidepressant medications.
A carbohydrate-rich/protein-poor diet has been shown to increase
the ratio of Trp:large neutral amino acids (LNAA). The diet
prevented stress-induced mood deterioration and cortisol response
in individuals vulnerable to stress (defined by high neuroticism
scores; Markus et al., 1998). Carbohydrate-rich/protein-
poor diets are, however, not healthy on a day-to-day basis
(Cristensen, 1997), and even a small amount of protein blocks
the rise of Trp:LNAA.
Recently, an even larger effect on stress response was obtained
with a diet containing Trp-rich a-lactalbumin protein. a-Lactalbu-
min has the highest Trp concentration of all protein fractions
(Heine et al. 1996). This diet increased plasma Trp:LNAA by
43–48%, which is twice the augmentation found with a carbo-
hydrate-rich/protein-poor diet (Markus et al. 2000, 2002), or after
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7 d of daily Trp treatment (Chouinard et al. 1985). a-Lactalbumin
had no side-effects, and improved mood and attenuated cortisol
responses to stress in stress-vulnerable subjects (students with
high neuroticism scores) but not in controls (low neuroticism;
Markus et al. 2000). Orosco et al. (2004) found that a-lactalbumin
had an anxiolytic effect in rats and increased 5-HT turnover in hip-
pocampal areas. Since depression-vulnerable individuals are most
likely to be affected by 5-HT manipulations, it seems worthwhile
exploring the effects of a-lactalbumin in this group.
The present study was designed to investigate the effects of
a-lactalbumin in depression-vulnerable individuals and in healthy,
non-vulnerable controls. Based on previous research (Markus et al.
2000, 2002), we expected to find a protective effect of a-lactalbu-
min on stress-induced mood deterioration and cortisol response,
rather than a direct effect on mood. Furthermore, we expected
these effects to occur only in the depression-vulnerable group.
Materials and methods
Subjects
Eligible subjects were between 18 and 65 years of age and had
either a history of a major depressive episode (patient group) or
no history of mental disorder and no first-degree relative with a
major depressive disorder (control group). Subjects were euthy-
mic and were selected not on the basis of neuroticism scores
(Markus et al. 2000, 2002) but on a history of depression.
Approximately 60% of people with high neuroticism scores
actually develop a depression (Gallagher, 1990; Ormel et al.
2001; Kendler et al. 2004). Since long-term studies have shown
that up to 85% of recovered depressed patients experience a
recurrence (Mueller et al. 1999), a past history of depression is
a better marker of vulnerability.
In both groups, exclusion criteria were: current mental disorder;
past psychotic disorder; substance abuse in the past 3 months or
excessive dieting or binge eating, as defined by the Diagnostic
and Statistical Manual of Mental Disorders-IV (DSM-IV;
American Psychiatric Association, 1994). Furthermore, subjects
in both groups had low levels of depressive symptoms
(Montgomery Asberg Depression Rating Scale (MADRS) score
,8), were not colour-blind or dyslexic, had been free of anti-
depressant medication for at least 3 months, had a normal body
weight (BMI 18–27 kg/m2), kept to a regular diet and were
free of neuroendocrine or neurological disease. Female subjects
were not pregnant or lactating, had a regular menstrual cycle or
were postmenopausal. Premenopausal women who were not
taking a contraceptive pill were tested during their mid-to-late fol-
licular phase (days 4–10), whereas premenopausal women taking
a contraceptive pill participated during the period in which they
actually took the pill. The groups were matched on gender, age
and education level.
Design
The study was conducted according to a double-blind crossover
design. Subjects were given balanced isoenergetic meals contain-
ing a-lactalbumin-enriched whey protein or casein protein (pla-
cebo). Treatment order was balanced over two sessions,
separated by 4 weeks.
Instruments
Standardised, validated instruments were used to assess diagnosis,
depressive symptoms, mood states and personality. The Struc-
tured Clinical Interview for DSM-IV (First et al. 1995) was
used to verify diagnostic inclusion and exclusion criteria.
Depressive symptoms were measured with the MADRS
(Montgomery & Asberg, 1979), a ten-item interviewer-rating
scale, and the self-rating Beck Depression Inventory (BDI-II;
Beck et al. 1996; Van der Does, 2002a).
The Profile of Mood States (POMS; McNair et al. 1971; Wald &
Mellenbergh, 1990) measures ‘depression’, ‘anger’, ‘fatigue’, ‘ten-
sion’ and ‘vigor’. Neuroticism was measured to facilitate compari-
son with previous research (Markus et al. 2000, 2002); the Eysenck
Personality Questionnaire (Eysenck et al. 1985) was used.
Cognitive reactivity, a psychological vulnerability marker of
depression, was also measured, using the Depressed States Check-
list (DSC; Teasdale & Cox, 2001) and the Leiden Index of
Depression Sensitivity (Van der Does, 2002b). The DSC consists
of items that ‘objectively’ describe a depressed mood (e.g. sad,
unhappy), and items that also have a self-devaluative denotation
(e.g. useless, a failure). Cognitive reactivity is the ratio of the
endorsed self-devaluative and objective items (Teasdale & Cox,
2001). The Leiden Index of Depression Sensitivity is a self-rating
scale of cognitive reactivity, with subscales ‘hopelessness’, ‘rumi-
nation’, ‘harm avoidance’, ‘aggression’, ‘control/perfectionism’
and ‘acceptance/coping’ (Van der Does, 2002b).
Procedure
Depressed patients who had participated in a psychotherapy trial
1–2 years earlier were sent information and invited to participate.
Subjects were also recruited through advertisements in a local
newspaper, and through advertisements and leaflets at the local
mental health centre and at several university buildings. Individ-
uals who expressed interest were interviewed by telephone. If the
inclusion and exclusion criteria appeared to be met, more infor-
mation was sent, and people were invited for a screening session
at the hospital, during which the Structured Clinical Interview for
DSM-IV and MADRS was administered by trained clinical psy-
chologists. Information about previous antidepressant treatments
and the course and duration of depressive episodes was also
obtained, and questionnaires were completed. Subjects gave
informed consent to participate prior to filling out the question-
naires. The first session was scheduled for approximately 1
week after the screening session, or somewhat later depending
on the menstrual cycle phase.
Subjects arrived at the laboratory at 09.00 hours after fasting
overnight. They were instructed not to use alcohol for 24 h prior
to the sessions and to arrive well rested. They received breakfast
and lunch including either a-lactalbumin or casein. In the morning
and afternoon, a battery of cognitive tests was administered, the
results of which are reported elsewhere (Booij et al. 2005). During
the day, two blood samples and four cortisol samples were taken.
The session finished at around 15.30 hours, and subjects were
instructed to resume their regular meals. The outline of sessions is
shown in Table 1. Subjects were paid e 80 for participation. Subjects
were tested individually at a clinical research unit of Leiden
University Medical Center.
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Intervention
The a-lactalbumin and casein diets used in the present study were
identical to the diets used by Markus et al. (2000, 2002). Diets con-
tained 1229 kJwith 5·2% energy as protein, 84·2% energy as carbo-
hydrate and 10·6% energy as fat, composed of standard products
(Netherlands Nutrition Center). Each breakfast and lunch consisted
of one slice of bread, 10 g butter, 15 g fruit jelly, 200ml grape juice
and a chocolate drink. The two diets were similar in appearance and
in macronutrient content with the exception of the composition of
the chocolate-flavoured drink, for which the protein sources dif-
fered. Apart from breakfast and lunch, subjects were only allowed
to drink water and one cup of tea or coffee.
The nutrient composition and amino acid profile of both choco-
late drinks are displayed in Table 2. The amounts of Trp in thea-lac-
talbumin and casein diets were 12·32 g/kg (Trp:LNAA 8·7) and
9·51 g/kg (Trp:LNAA 4·7), respectively. The chocolate drink was
prepared within 20min before breakfast (first drink) and 20min
before lunch (second drink). To compensate for any taste differ-
ences, sugar was added to all the drinks (10 g; see Table 2). All
meals were supervised to make sure that all foods were consumed.
Stress task
An impossible mental arithmetic task, performed under noise
stimulation, was used as an experimental stressor. Subjects were
given eighteen successive 1min trials, during which they had to
do mental arithmetic under time constraints, while different
levels of industrial noise (65, 70 or 80 dB) were presented through
a headphone. Multiple choice questions were presented on a com-
puter screen one at a time. A specified number of calculations
(called the criterion) had to be solved correctly. Subjects were
led to believe that they could control the intensity of noise by
their performance. If they failed the criterion, the computer
would set the noise level higher during the next trial; if, however,
they met the criterion, they could choose the noise level them-
selves. Before the actual test, subjects were given two practice
trials during which they had to solve a few calculations without
noise and then with each of the three noise levels successively.
The credibility of the task as well as motivation were enhanced
by providing the subjects with constant on-screen feedback
about the criterion in a particular trial, the number of calculations
correctly solved and the time left for that trial.
Experimental stress was induced by manipulating the criterion
so that all subjects continued to fail on each trial and thus could
not choose the noise level for the next trial. The criterion was
always set at one sum above what subjects could manage, as cal-
culated from the average time per sum needed on the previous
trial. This task has been demonstrated to be uncontrollable and
to induce transient psychological and physiological stress
(Peters et al. 1998; Markus et al. 1999, 2000, 2002). The stress
task proved to be sensitive in crossover designs in studies by
Markus et al. In addition, the test affects perceived stress as
well as systolic and diastolic blood pressure (Peters et al. 1998).
Salivary cortisol
Cortisol samples were obtained with the Salivette sampling
device (Sarstedt, Nu¨mbrecht, Germany). With this procedure,
saliva was collected in small cotton swabs and stored in special
Salivette tubes at 2308C until centrifugation. Saliva samples
were centrifuged at 3000 rpm for 3min at 208C. Cortisol concen-
trations were determined without extraction using a competitive
chemiluminescence immunoassay.
A 20ml sample of saliva was pipetted into microtitre plate wells
coated with rabbit anti-cortisol antibodies. After the addition of
100ml cortisol conjugated with horseradish peroxidase (enzyme
conjugate), the mixture was incubated for 3 h at room temperature,
and the cells were washed to stop the competition reaction. After
addition of the chemiluminescence substrate solution containing
peroxide and luminol, luminescencemeasurements were performed
using a Berthold microtitre plate luminometer (Medical Labora-
tories, Mo¨nchengladbach, Germany).
Blood assessments
Total Trp and its concentration ratio to LNAA (valine, isoleucine,
leucine, tyrosine and phenylalanine) were determined by amino
acid analysis. Blood was collected in 4ml EDTA-containing
tubes, and plasma was isolated after centrifugation at 2650 g
at 20 8C for 20min. For the determination of (total) Trp
and LNAA, 400ml plasma was deproteinised using an equal
volume of 0·075 (w/v) sulphosalicylic acid in water, which conco-
mitantly contained 382mmol/l of the internal standard L-2,4-dia-
mino-butyric acid (Fluka, Milan, Italy). The supernatant was
isolated after centrifugation at 8000 g at 20 8C for 2min, filtered
through Millex 0·22mm, 25mm membrane filter units (Millipore,
Billerica, MA, USA); 60ml of this was analysed in 170min by
Table 1. Scheme of the sessions
Time Assessment
09.00 hours t21 Arrival, BDI-II, DSC, POMS, blood sample
10.00 hours t0 Breakfast
12.00 hours t2 Lunch
13.30 hours t3·5 Cortisol (1), blood sample, POMS, DSC
14.35 hours t4·5 Cortisol (2), POMS
14.40 hours Stress induction
15.00 hours t5 Cortisol (3), POMS, DSC
15.10 hours t5·2 Cortisol (4), debriefing
BDI-II, Beck Depression Inventory-II; DSC, Depressed States Checklist; POMS, Profile of
Mood States.
For details of diets and procedures, see p. 416.
Table 2. Composition of the chocolate drinks used in the a-lactalbumin and
casein diets
a-Lactalbumin diet Casein diet
Composition (g)
a-Lactalbumin-enriched whey protein 20 0
Sodium caseinate 0 20
Cocoa 3·5 3·5
Granulated sugar 10 10
Water 200 200
Amino acid profile (g/kg)
Isoleucine 27·61 31·80
Leucine 47·56 59·31
Phenylalanine 20·80 32·24
Tyrosine 16·82 33·13
Valine 29·52 44·09
Tryptophan 12·32 9·51
Tryptophan:large neutral amino acids
(weight %)
8·70 4·70
For details of diets and procedures, see p. 416.
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means of ion-exchange chromatography and ninhydrin derivatisa-
tion on a Biochrom 20 automated amino acid analyser
(Pharmacia, Uppsala, Sweden) using standard conditions for phys-
iological amino acid separation.
Statistical analyses
Group differences in demographic characteristics were examined
with independent-sample t tests. The effects of the interventions
on cortisol response were analysed by means of repeated-measures
ANOVA using general linear models. Within-subjects factors were
intervention (a-lactalbumin v. casein) and time of assessment
(before and after stress); the between-subjects factor was group
(recovered depressed v. controls). All mood scores were analysed
using non-parametric tests (Wilcoxon and Mann–Whitney U). A
test was considered to be significant when the P value was 0·05 or
less. SPSS 11.5 (SPSS Inc., Chicago IL, USA) was used.
Ethical considerations
The study was approved by the Medical Ethics Committee of
Leiden University Medical Center. Previous studies using casein
or a-lactalbumin diets have shown that the procedure is safe,
with no side-effects (Markus et al. 2000, 2002). Prior studies
have used the stress induction task (Peters et al. 1998; Markus
et al. 1999, 2000, 2002). There are no indications that the cognitive
tasks or the stress task elicit the recurrence of depression.
Results
Data screening
A very small number of missing values on items of the symptom
questionnaires were replaced by the grand mean. No statistical
outliers were detected. Twenty-two blood samples (13% of the
total) were not available owing to difficulties with venepuncture.
The amino acid levels and ratios were all normally distributed.
Cortisol values and the scores on the mood subscales were not;
these data were 10log-transformed. Subscales of the POMS and
DSC were analysed using non-parametric tests as the data were
highly skewed and transformations were unsuccessful.
Sample characteristics
Fifty-seven individuals were invited for the screening session,
eight of whom did not meet the inclusion and exclusion criteria.
Three eligible subjects dropped out after the screening session,
and another three dropped out after the first test day for various
reasons. A total of forty-three subjects completed both test
days. As shown in Table 3, there were no significant differences
in age, education and gender distribution between groups.
MADRS scores in both groups were low and did not differ
significantly. The only significant difference was found on BDI-
II scores at screening, with recovered depressed subjects having
higher scores. However, BDI-II scores were low and well
within the normal range in both groups. As shown in Table 4,
the recovered depressed patient group had a mean age of
depression onset at 19·9 years. The mean number of episodes
was two. Approximately one-third had taken antidepressant medi-
cation in the past, and almost half had a first-degree relative with
depression.
Significant baseline differences between the groups were found
on the POMS depression (Z 22·21, P¼0·03), POMS fatigue
(Z 22·06, P¼0·04), POMS total (Z 22·31, P¼0·02) and DSC
self-devaluative (Z 22·42, P¼0·02) subscales. Trends were
found for POMS tension (Z 21·77, P¼0·08) and DSC affective
(Z 21·79, P¼0·07). The recovered depressed subjects had
Table 3. Demographic and clinical characteristics
(Mean values and standard deviations)
Recovered
depressive (n 23)
Healthy controls
(n 20) Recovered v. controls
Mean SD Mean SD t/Z df P
Age 30·0 9·7 27·0 10·1 0·99 41 0·32
Female (%) 91·3 85 (x2) 0·41 1 0·52
Educational level* 4·9 0·8 5·1 0·6 21·07 41 0·29
BMI (kg/m2) 22·8 2·5 21·7 2·1 1·60 41 0·12
MADRS 1·3 1·6 0·8 1·6 1·03 41 0·31
BDI-II 4·4 4·5 1·5 2·2 2·83 41 0·008
EPQ-R psychoticism 3·2 1·7 2·6 1·3 1·29 41 0·20
Extraversion 7·6 3·4 9·7 2·3 22·31 41 0·03
Neuroticism 5·6 2·3 2·6 2·0 4·43 41 ,0·001
Social desirableness 5·7 2·1 5·8 2·1 20·10 41 0·92
LEIDS hopelessness 4·6 3·0 1·4 1·0 4·76 41 ,0·001
Aggression 5·8 3·9 3·1 3·1 2·45 41 0·02
Perfectionism 8·0 4·7 4·1 3·3 3·18 41 0·003
Harm avoidance 9·5 4·8 3·5 2·6 5·23 41 ,0·001
Rumination 10·7 4·9 5·6 2·5 4·39 41 ,0·001
Acceptance/coping 2·2 3·9 1·0 1·7 1·38 41 0·18
Total score 40·8 18·9 18·5 9·8 4·94 41 ,0·001
DSC affective 26·5 9·8 21·1 5·0 1·79 0·07
Self-devaluative 22·0 6·6 17·0 2·6 2·42 0·02
MADRS, Montgomery-Asberg Depression Rating Scale; BDI-II, Beck Depression Inventory-II; EPQ-R, Eysenck Personality Questionnaire-Revised;
LEIDS, Leiden Index of Depression Sensitivity; DSC, Depressed States Checklist.
* On a scale of 1–6.
For details of subjects and procedures, see p. 416.
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higher scores on all these subscales. On the Eysenck Personality
Questionnaire, groups differed on extraversion (F(1,41) 5·32,
P¼0·03) and neuroticism (F(1,41) 19·6, P,0·001). The neuroti-
cism scores of the recovered depressed group were above average
to high, according to published norms for Dutch populations
(Sanderman et al. 1995). The two groups also differed on most
subscales of the Leiden Index of Depression Sensitivity. After
controlling for depressive symptoms (BDI-II), only the following
subscales remained significant: neuroticism (F(1,40) 12·9,
P¼0·001), and the Leiden Index of Depression Sensitivity sub-
scales of hopelessness (F(1,40) 13·6, P¼0·001), control/perfec-
tionism (F(1,40) 5·6, P¼0·02), harm avoidance (F(1,40) 16·5,
P,0·001), rumination (F(1,40) 10·5, P¼0·002) and total
(F(1,40) 13·9, P¼0·001).
Effect of dietary manipulations on amino acids
As shown in Table 5, plasma Trp concentrations and Trp:LNAA
did not differ at baseline between groups. Repeated-measures
analyses with intervention and time as within-subjects factors,
and group as the between-subjects factor, on Trp:LNAA revealed
a significant effect of intervention (F(1,29) 84·3, P,0·001).
Trp:LNAA increased significantly by 20·9% compared with base-
line after the a-lactalbumin diet and decreased by 30·0% after the
casein diet. The relative rise of Trp:LNAA was 73·8% higher
after a-lactalbumin than after casein. We also found significant
effects of time (F(1,29) 7·1, P¼0·013) and of the intervention £
time interaction (F(1,29) 193·3, P,0·001). There was no main
effect of group, nor any interaction effects involving group.
Effects of stress on cortisol
Two cortisol samples were collected after the stress task, t5
(directly after the stress) and t5·2 (10min later). The higher corti-
sol level of these two was used in the analyses (tmax). Repeated-
measures analyses with intervention and time (before and after
stress) as within-subjects factors, and group as the between-
subjects factor, on cortisol level did not reveal the expected inter-
action of intervention £ group £ time (F(1,41) 0·1, P¼0·71).
We did, however, find a significant main effect of time (F(1,41)
9·7, P¼0·003), reflecting an increase in cortisol level after
stress. No other main or interaction effects were found. Cortisol
levels are shown in Table 6.
To check for any order of intervention effects, order, instead of
group, was included in the analysis as a between-subjects factor.
No interaction effect of order £ intervention was found (F(1,41)
0·01, P¼0·93). A trend for an interaction effect of intervention £
time £ order was found (F(1,41) 3·4, P¼0·07), caused by the fact
that cortisol did not rise after stress for subjects who had the a-
lactalbumin diet on the second day. a -Lactalbumin did not
have this protective effect for subjects who had that diet on the
first day.
Although Markus et al. (1998, 2000) found cortisol responses
in both men and women – using the same stressor – previous
research with other stressors has shown that response may be
dependent on gender, and for females on menstrual cycle and
use of oral contraceptives (Kirschbaum et al. 1999). We therefore
divided the total group of forty-three subjects into three groups:
men (n 5), women taking (n 23) and women not taking (n 15) hor-
monal contraceptives. This analysis showed significant interaction
effects of intervention £ group (F(2,41) 4·3, P¼0·02), and of
time £ group (F(2,41) 3·8, P¼0·03). Women taking contracep-
tives had no cortisol response to stress. Women not taking hor-
mones had a small rise of cortisol on the casein day and not on
the a-lactalbumin day, whereas men showed the reverse pattern.
Because of the small groups and the opposite effects in men
and women, no further analyses were carried out.
Table 4. Clinical characteristics of the recovered depressed subjects
Mean SD
Age of onset (years) 19·9 7·7
Number of episodes 2·0 0·9
Antidepressant medication (past) 34·8 %
Antidepressant treatment (ever) 78·3 %
Family history (first degree)
of major depressive disorder
47·8 %
Current psychotherapy 13 %
For details of subjects and procedures, see p. 416.
Table 5. Plasma tryptophan (mmol/l) and tryptophan:large neutral amino
acid (Trp:LNAA ratio)
(Mean values and standard deviations)
Casein a-Lactalbumin
Mean SD Mean SD
Tryptophan Morning 50·5 11·2 50·8 10·1
Afternoon 57·3 8·9 87·9 14·5
Trp/LNAA Morning 0·11 0·02 0·11 0·02
Afternoon 0·08 0·01 0·13 0·02
For details of diets and procedures, see p. 416.
Table 6. Cortisol (nmol/l) before (t4·5) and after (tmax) stress
(Mean values and standard deviations)
Casein a-Lactalbumin
Before stress After stress Before stress After stress
Mean SD Mean SD Mean SD Mean SD
Healthy controls (n 20) 5·1 6·4 5·9 6·3 5·7 5·1 5·4 2·8
Recovered depressed subjects (n 23) 5·2 3·8 7·4 7·0 4·5 1·8 6·4 6·4
High-neuroticism subjects (n 27) 5·1 3·7 6·8 6·6 4·2 2·0 5·0 4·1
Low-neuroticism subjects (n 16) 5·4 7·1 6·5 7·0 6·5 5·3 7·6 6·1
For details of subjects and procedures, see p. 416.
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Effects of a-lactalbumin on mood
To investigate any direct effects of a-lactalbumin onmood, we ana-
lysed the differences inmood between themorning (t21) and the first
afternoon rating (t3·5). On the a-lactalbumin day, the POMS tension
(Z 22·6, P¼0·008) and DSC self-devaluative (Z 22·0, P¼0·04)
ratings decreased. A trend was found for POMS anger (Z 21·9,
P¼0·06). However, on the casein day, POMS anger (Z 2·9,
P¼0·003), depression (Z 22·8, P¼0·005) and fatigue (Z 22·1,
P¼0·035), as well as both DSC scores, decreased. During thea-lac-
talbumin session, recovered patients had (almost) significantly
larger decreases in DSC self-devaluative (Z 22·2, P¼0·03) and
POMS depression (Z 21·9, P¼0·06) scores than controls. The
difference in self-devaluative change scores between groups was
also significant in the casein condition (Z 22·2, P¼0·03). No
other group differences were observed. Thus, mood improved
slightly after both interventions. Only POMS depression scores
tended to improve more in the recovered depressed group than in
the control group on the a-lactalbumin day. However, this effect
was due to a floor effect in the control group. So, as hypothesised,
no direct effects of a-lactalbumin on mood were found.
Effects of stress on mood
To investigate any protective effects of a-lactalbumin on the
response to stress, scores on the POMS and DSC scales before
and after stress were analysed. Mood scores are shown in
Table 7. In both conditions, significant increases in DSC affective
and self-devaluative scores were observed. In the a-lactalbumin
condition, POMS anger, tension, depression and total scores
increased, fatigue tended to increase and vigor decreased in
response to stress. In the casein condition, similar changes were
found for POMS anger, tension and total scores. A trend was
found for depression in the casein condition. In the a-lactalbumin
condition, recovered depressed subjects showed a significantly
larger increase in self-devaluative scores compared with controls
(Z 22·0, P¼0·04). There were no differences between groups in
POMS change scores in response to stress.
To analyse the effect of order on mood response to stress,
Kruskal–Wallis tests were performed on mood change scores
with order as the grouping variable. A significant effect of order
on vigor change score was found in both the recovered depressed
group (x2 5·8, P¼0·016) and the control group (x2 4·3, P¼0·037),
but only for casein. The decrease of vigor was smaller if casein
was given on day 2, suggesting that the stressful nature of the task
might have been slightly reduced on the second day. The same
effect was found for the DSC, but then only in the controls. No
other effects of order were found.
Results therefore showed that the stressor affected mood in
both the a-lactalbumin and the casein condition. The effects
were, however, much smaller than expected, and there were no
differences between the two diets.
To explore the reasons for these unexpected findings, we also
looked at possible effects of past antidepressant medication use,
family history of depression and cognitive reactivity on cortisol
response and on mood. Again, only significant effects of time
were found. Previous research (Markus et al. 2000) using the
same paradigm in a healthy population divided on the basis of neur-
oticism scores found effects of a-lactalbumin on mood and cortisol
response. Therefore, we reallocated subjects to high- and low-neur-
oticism groups (median split; see Table 6). As in the previous ana-
lyses contrasting previously depressed and never-depressed
subjects, no between-group differences in cortisol response were
found. A significant interaction effect of intervention £ group
(F(1,41) 7·9, P¼0·007) and a main effect of time (F(1,41) 10·3,
P¼0·003) were again found. Further analyses indicated that the
low-neuroticism group had higher cortisol levels on the a-lactalbu-
min day than on the casein day and that both groups showed an
increase in cortisol level after stress.
Table 7. Mood before and after experimental stress
(Mean values and standard deviations)
Casein diet a-Lactalbumin diet
Before stress After stress Before stress After stress
Mean SD Mean SD Mean SD Mean SD
Healthy controls (n 20)
POMS
Anger 7·2 0·4 8·4 1·8 7·4 1·1 8·6 1·8
Tension 5·4 0·7 5·9 1·2 5·2 0·4 6·3 2·0
Depression 8·0 0·0 8·2 0·5 8·0 0·0 8·2 0·4
Vigor 15·5 4·1 15·10 4·3 15·3 4·2 14·0 4·1
Fatigue 7·6 2·1 7·9 1·8 7·5 1·5 7·9 1·8
DSC affective 15·1 0·7 15·7 1·8 15·1 1·1 16·2 2·3
DSC self-devaluative 14·0 0·0 14·6 1·1 14·0 0·0 14·7 1·4
Recovered depressed (n 23)
POMS
Anger 7·5 1·4 8·7 3·0 7·2 0·5 8·3 1·9
Tension 5·4 0·6 6·8 2·5 5·4 0·8 6·8 2·8
Depression 8·2 0·5 8·5 0·9 8·1 0·4 8·5 1·5
Vigor 11·7 5·2 10·9 4·1 12·5 4·6 11·0 3·9
Fatigue 8·2 2·5 8·8 2·4 8·5 3·2 9·1 3·4
DSC affective 15·0 1·0 16·4 2·3 15·6 2·0 17·0 4·0
DSC self-devaluative 14·0 0·2 15·9 3·4 14·1 0·5 15·9 2·4
POMS, Profile of Mood States; DSC, Depressed States Checklist.
For details of diets and procedures, see p. 416.
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Discussion
This study used an a-lactalbumin-enriched diet to increase plasma
Trp and Trp:LNAA ratio in recovered depressed subjects and con-
trols. We hypothesised that a-lactalbumin would have a protec-
tive effect against stress, particularly in recovered depressed
subjects. Although dietary a-lactalbumin led to the expected
rises in Trp and Trp:LNAA, only minimal effects were found
on mood and cortisol response to stress.
The afternoon values of Trp:LNAA were 73·8% higher after
the a-lactalbumin diet than after the casein diet, which is compar-
able to earlier findings (J A J Schmitt et al., unpublished results).
In previous studies, increasing Trp:LNAA by 43–48% (com-
pared with casein) caused a decrease in the cortisol response to
stress and reduced depressive feelings under stress in stress-vul-
nerable subjects (Markus et al. 2000). We found rather small
effects of the stressor on cortisol and mood, and these changes
were independent of group and diet. These finding are at odds
with the experimenters’ observations and subjects’ comments,
which indicated that the procedure was experienced as rather
stressful and unpleasant. However, a trend of an order effect
was found: a-lactalbumin had the expected protective effect on
cortisol response if taken on the second day. Also, the change
in vigor in response to the stress task was greater on the first
day than on the second day, when the casein diet was given. How-
ever, no order effects were apparent for all other measures of
mood. Nonetheless, the stressor may have been slightly more
severe during its first presentation (when subjects were less pre-
pared). It would follow that the protective effects of a-lactalbu-
min were insufficient on the first day.
Markus et al. (2000), using the same stressor, found a protective
effect of a-lactalbumin on stress-induced changes in mood and cor-
tisol in students with high neuroticism scores. There are a few poss-
ible explanations for our contradictory results. First, our recovered
depressed subjects may have been ‘too healthy’. This group’s
MADRS scores were below 8, they were not taking antidepressant
medication, and they were relatively young, so few previous
depressive episodes had occurred. Furthermore, the end of the last
episode had been on average a little more than 2 years previously,
also suggesting that our patient group was relatively healthy and
stable. However, the expected group differences on personality
(neuroticism) and markers of depressive vulnerability (cognitive
reactivity) were observed, implying that the recovered group was,
as a group, more vulnerable than the controls. The mean scores on
these scales were above the norms for healthy subjects (Eysenck
et al. 1985; Sanderman et al. 1995; Van der Does, 2005) but still
not extremely high. Furthermore, this explanation is unlikely
becauseMarkus et al. found an effect ofa-lactalbumin in a probably
even healthier group.
A second possible explanation is that the intervention was not
strong enough. As will be reported separately elsewhere, a-lactal-
bumin did have an effect on cognitive function in both groups
(Booij et al. 2005). These findings suggest that the intervention
did not fail, but a 1 d a-lactalbumin diet may be too weak also
to affect mood and cortisol responses to stress in recovered
patients. Future studies may investigate a higher dose or a
longer duration of the diet.
The protective effects of a-lactalbumin on cortisol response
were also not observed, but this part of the study was hampered
by the unexpectedly small effects of the experimental stressor.
Previous studies using a different stressor – the Trier Social
Stress-Task – have reported gender differences in cortisol
response (Kirschbaum et al. 1999): men show the largest cortisol
response, followed by women in their late luteal phase, women in
the follicular phase and women taking oral contraceptives. The
women in our sample were tested in the late-follicular phase of
the menstrual cycle (days 4–10) to minimise possible mood
effects. For the purpose of measuring cortisol level, we might
better have tested them at a later stage of the cycle. Detailed ana-
lyses of gender differences in cortisol response were hampered by
the relatively small number of subjects in our sample and by the
fact that only five men were included. On the other hand, no
gender differences in cortisol response were found in previous
studies that used the same stressor as the current study (Markus
et al. 2000, 2002).
Another issue often raised in stress research is the influence of
context, including the person leading the experiment. In the Trier
Social Stress-Task, the people conducting the experiment are
instructed to be rejecting and ‘unkind’ to the participant, adding
to the level of stress that is meant to be induced by the task. In our
study, however,we used a computerised stress task. The instructions
were also all presented by computer. The possibility cannot be
excluded that the experimenters in the Markus et al. studies were
more ‘unkind’ to the subjects than in the present study, implying
that we may have missed the social component of the stressor.
If both our results and those of Markus et al. are replicable, this
implies that neuroticism and a history of depression are not simi-
lar concepts in terms of 5-HT vulnerability. Recent studies using
the acute tryptophan depletion method found no relationship
between neuroticism and the acute tryptophan depletion response
(Stewart et al., 2002; L Booij and AJW Van der Does, unpub-
lished results). Another finding from acute tryptophan depletion
research is that a depressive response to this manipulation of
5-HT function is mostly found in selective serotonin reuptake
inhibitor-treated patients (Delgado et al. 1999). The same may
be true for the effects of a Trp-enriched diet. a-Lactalbumin poss-
ibly has a clearer effect in recovered depressed subjects taking
selective serotonin reuptake inhibitors.
In conclusion, a-lactalbumin increased plasma Trp and
Trp:LNAA in recovered depressed individuals and in healthy con-
trols, but no direct or protective effects were found on mood or on
stress-induced cortisol and mood responses. Since cognitive
effects did occur (L Booij et al., unpublished results), future
studies may investigate the effects of longer-term diets (e.g. 3 d)
or may investigate different samples (e.g. medicated patients).
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